Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here
Pharm-Olam’s therapeutic areas of focus have been built to provide an ecosystem of cross-functional, therapeutically aligned teams. These areas of focus create synergies and efficiencies that help to ensure your rescue study or trial optimization solutions are optimally positioned to help your clinical trial reach its goals and milestones.
Our dedicated team of cancer researchers create solutions and provide consulting focused on the needs of your sites and patients – and can bring your study back on track.
Our dedicated staff for infectious disease and vaccine research can support your current sites and tap into our global network to bring your study back on track leveraging our vast expertise from immunizations to immunotherapy.
With more than 100 rare and orphan disease clinical trials completed, we have deep expertise in rare and are prepared to meet the unique challenges of these studies.
We understand that allergy clinical trials and asthma clinical studies require present a variety of unique challenges that our Allergy CRO team is well-equipped to handle.
Pharm-Olam has the expertise, investigator relationships, and supportive technology to effectively deliver autoimmune clinical research studies.
Its time to stop the fall of your study, and get it back on track. When issues like delayed enrollment and timelines, budget problems, regulatory issues and resource constraints threaten to derail your study, our trial optimization or rescue services can help. Specializing in rescue study services requires us to be efficient and move quickly to analyze your study’s needs. From there, we design customized solutions to help get your clinical trial back on track.
Your official transition plan will be initiated by our team of experts from specialized areas who work in parallel to execute regulatory approvals, site agreements and logistical requirements. What’s more, they work to build productive relationships that better position your clinical trial for success.
Since slow recruitment is the number one clinical trial issue, we have a rescue startup team that quickly analyzes your options for enrollment. We also provide you with a global network and decentralized operations model that allows us to quickly initiate sites in countries that typically have far higher rates of recruitment than the U.S. or Western Europe. Whether you need additional sites in an active country, sites in new countries or want to transfer an ongoing study, we can help you meet your enrollment needs.
The best part is that our proven processes and solutions are designed to improve communication between all teams to help alleviate future study issues before they arise.
Looking for assistance on how to plan and execute a rescue scenario? Watch our on-demand webinar - Rescue Your Study: A Sponsor's Playbook.
Clinical trials continue to evolve and so do the methodologies used to support and provide the...
Rare disease drug development varies from the pathways seen in more established indications. The...
Pharm-Olam is committed to following our industry’s best practices – sometimes even those from...